Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
about
Tricyclic antidepressant pharmacology and therapeutic drug interactions updatedA review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdoseMethylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical predictionAbuse and misuse of antidepressantsComparative Toxicity of Tapentadol and Tramadol Utilizing Data Reported to the National Poison Data System.Comparison of acute lethal toxicity of commonly abused psychoactive substances.Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.Tolerability and safety of fluvoxamine and other antidepressants.Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose.A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status.Advances in the treatment of depressionEvidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder.The effect of decontamination procedures on the pharmacodynamics of venlafaxine in overdose.Acute poisoning: understanding 90% of cases in a nutshellCardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.Treatment of anxiety disorders with venlafaxine XR.A comparison of venlafaxine and SSRIs in deliberate self-poisoningLack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit.Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management.A fatal case of venlafaxine overdose.Predictive factors for generalized seizures after deliberate citalopram overdoseElectrocardiogram changes and arrhythmias in venlafaxine overdose.CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity.A retrospective review of isolated duloxetine-exposure cases.Metabolic and toxicological considerations for obsessive-compulsive disorder drug therapy.Prescribing for depressed adolescents: office decision-making in the face of limited research evidence.Seizures after single-agent overdose with pharmaceutical drugs: analysis of cases reported to a poison center.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Venlafaxine as the 'baby ecstasy'? Literature overview and analysis of web-based misusers' experiences.Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.Pramipexole Overdose Associated with Visual Hallucinations, Agitation and Myoclonus.ABCB1 gene polymorphisms are associated with fatal intoxications involving venlafaxine but not citalopram.Desvenlafaxine overdose and the occurrence of serotonin toxicity, seizures and cardiovascular effects.Self-poisonings with tricyclic antidepressants and selective serotonin reuptake inhibitors in Tehran, Iran.European Medicines Evaluation Agency bans dextropropoxyphene: a landmark decision for clinical toxicology?Single-agent duloxetine ingestions.The effect of decontamination procedures on the pharmacokinetics of venlafaxine in overdose.Seizures during antidepressant treatment in psychiatric inpatients--results from the transnational pharmacovigilance project "Arzneimittelsicherheit in der Psychiatrie" (AMSP) 1993-2008.
P2860
Q24564967-D8DD1743-65D8-4899-9C20-F86F3BC46185Q24606269-89F35290-2B09-4CDF-A8E2-7BE777A27928Q24678060-88D34B34-C8B3-468B-B3B1-D52341ECC530Q27691354-333D0BA2-7415-4B87-82B4-3164ECE31A65Q30993522-14831729-B378-4891-91DC-60CFBC9CF652Q33202857-F4884042-3AE5-42DE-ABEA-B390ABDE9499Q33632295-A5B347CA-CEF2-464F-8A4F-4BCC8BF921E5Q33995120-671F22AB-40F6-4D02-975B-F67069A79483Q34099069-C4061146-0AAE-4AF0-91AD-512368AEBD09Q34347727-3D396FE5-8ED3-472E-A38E-073B23552072Q34475037-B57859EB-4FFC-4D86-9EE2-4F41E9DDF09DQ34496251-DF00B387-EAD2-4A82-9F97-69739F6148C3Q34590507-00F26767-917A-4F96-922A-B98AC505BAA2Q34636674-B36FECB8-50DF-4BEA-AE4C-5FBD46FBD00EQ35120633-4B9955E5-8BB8-4A37-AF27-4904D51C5687Q35521661-483F3007-E2C5-48C3-BC1E-8D5CBC6A7960Q36024615-2A349E5A-2564-4DA7-A869-63D75C923C2DQ36419538-0B4B04A1-666B-45EB-B045-DFA128DB8339Q36549123-CC9D438F-A597-4DFC-98A4-C09DCF7BAFADQ36759259-B32E9DC7-22EE-4389-AD86-72911E3FDAAEQ36814510-755ADAE8-3E2A-4648-84F2-C8221F0598C5Q37109313-A036BF5E-40EF-41EC-870E-330252E42482Q37175817-5FB3A6A4-6443-4F98-9AB2-04076EE89F6DQ37201707-F58D5F76-E13E-42C1-AC2F-78AB35006203Q37689364-B9BC6BFE-FCDC-4D40-8596-F57D812B2C4FQ38077304-B6FD5C7E-AA55-442E-8AC6-06AB3CC69719Q38092129-D2E68B0E-9C3C-4100-900A-72E1009D3148Q38195068-AC1A4B98-1239-4C23-A933-5510E3EDF75EQ38213129-1A9E6342-F0C5-4C75-A3C1-B473882F9041Q38476909-5CE4D09C-EFE2-460C-8682-AE054E20BDD4Q38555616-58EE61ED-5E77-4351-ADCD-900CED6B43A2Q38731079-8E742762-7A5E-4330-A2CC-91904B54DCE9Q38762150-BF52B3DC-EB4A-4AC7-88C6-C75B322CF6D2Q39447754-010F29A1-E072-48ED-935A-C9BAD05ED9FDQ40583867-C029B7E7-F7E7-4E03-B19F-76F90B6F7646Q43239655-3052F704-26BE-4D6F-B66D-AB6CEACE812AQ43272009-2301553D-10CA-4468-B298-02AFBD475AF1Q43446891-6BA7ED9C-8B18-43A7-8212-30BD061214B3Q43592461-F75F47AC-2D9B-4141-8BFE-F8E9C027E3FFQ43800445-9F9F8341-4F99-4E1C-BD4E-39A59B033CAF
P2860
Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@ast
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@en
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@nl
type
label
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@ast
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@en
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@nl
prefLabel
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@ast
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@en
Relative toxicity of venlafaxi ...... to tricyclic antidepressants.
@nl
P356
P1476
Relative toxicity of venlafaxi ...... d to tricyclic antidepressants
@en
P2093
P304
P356
10.1093/QJMED/HCG062
P407
P577
2003-05-01T00:00:00Z